Category: Cibacron Blue

heraeus-targets

Impact of postoperative dexamethasone on survival, steroid dependency, and infections in newly diagnosed glioblastoma patientsImpact of postoperative dexamethasone on survival, steroid dependency, and infections in newly diagnosed glioblastoma patients

Background: We examined the impact of dexamethasone prescribed within the preliminary three postoperative weeks on survival, steroid dependency, and an infection in glioblastoma sufferers. Strategies: On this single-center retrospective cohort evaluation, we

heraeus-targets

Effects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exerciseEffects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exercise

Introduction: Emicizumab (Hemlibra: Roche Switzerland) is a, humanized, bi-specific monoclonal modified immunoglobulin G4 (IgG4) which binds human FX, FIX and activated FIX (FIXa) to imitate activated FVIII exercise. Intention: Consider the consequences

heraeus-targets

Diversity of Plasmids and Genes Encoding Resistance to Extended-Spectrum β-Lactamase in Escherichia coli from Different Animal SourcesDiversity of Plasmids and Genes Encoding Resistance to Extended-Spectrum β-Lactamase in Escherichia coli from Different Animal Sources

Antimicrobial resistance related to the unfold of plasmid-encoded extended-spectrum β-lactamase (ESBL) genes conferring resistance to 3rd technology cephalosporins is growing worldwide. Nonetheless, knowledge on the inhabitants of ESBL producing E. coli in